The Patent Finder

Cardiopep Pharma GmbH

Also on record
Records under this name other than patents Cardiopep Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Cardiopep Pharma GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,732,406Use of Natriuretic Peptide for Treating Heart Failure
Formerly held
Term ended
Term ended Nov 17, 2026 · High confidence
Term endedTerm ended Nov 17, 2026High confidence
US 8,710,006Use of natriuretic peptide for treating heart failure
Formerly held
Lapsed on the fee record
Ended Apr 29, 2026 · USPTO record
Lapsed on the fee recordEnded Apr 29, 2026USPTO record
US 9,023,794Use of natriuretic peptide for treating heart failure
Formerly held
Term ended
Ended no later than Apr 7, 2026 · USPTO record
Term endedEnded no later than Apr 7, 2026USPTO record
US 6,831,064Use of urodilatin for treating chronic kidney failure with residual kidney functions
Term ended
Term ended Aug 16, 2022 · USPTO record
Term endedTerm ended Aug 16, 2022USPTO record
US 8,293,711Use of natriuretic peptides for treating angioedema syndromes
Formerly held
Lapsed on the fee record
Ended Oct 23, 2020 · USPTO record
Lapsed on the fee recordEnded Oct 23, 2020USPTO record
US 7,033,997Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections
Lapsed on the fee record
Ended Apr 25, 2014 · USPTO record
Lapsed on the fee recordEnded Apr 25, 2014USPTO record
US 5,449,751Cardiodilatin fragment, process for preparing same and use thereof
Term ended
Term ended no later than Sep 12, 2015 · Low confidence
Term endedTerm ended no later than Sep 12, 2015Low confidence
US 5,665,861Cardiodilatin fragment, process for preparing same and use thereof
Term ended
Term ended no later than Sep 9, 2017 · Low confidence
Term endedTerm ended no later than Sep 9, 2017Low confidence
US 5,767,239Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same
Term ended
Term ended no later than Jun 16, 2018 · Low confidence
Term endedTerm ended no later than Jun 16, 2018Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited